Results from the TruSight Myeloid Sequencing Panel for each participant at each time point evaluated after GT
| Patient ID . | Age at GT (mo) . | Time point after GT (mo) . | Variant detected (pos/neg) . | Variant/description . | VAF, % . |
|---|---|---|---|---|---|
| 401 | 184 | 0∗ | Negative | — | — |
| 12 | Negative | — | — | ||
| 48 | Negative | — | — | ||
| 72 | Negative | — | — | ||
| 402† | 4 | 0∗ | Positive | KIT- VUS c.1700A>G (p.N567S) | 50 |
| 120 | Positive | KIT- VUS c.1700A>G (p.N567S) | 50 | ||
| 404† | 3 | 0∗ | Positive | KIT- VUS c.1700A>G (p.N567S) | 49 |
| 96 | Positive | KIT- VUS c.1700A>G (p.N567S) | 49 | ||
| 405 | 8 | 0∗ | Negative | — | — |
| 48 | Negative | — | — | ||
| 96 | Negative | — | — | ||
| 407 | 14 | 60 | Negative | — | — |
| 408 | 3 | 48 | Negative | — | — |
| 409 | 20 | 0∗ | Negative | — | — |
| 84 | Negative | — | — | ||
| 410 | 3 | 36 | Positive | TP53- LB c.1015G>A (p.E339K) | 48 |
| Controls ×5 | N/A | N/A | Negative | — | — |
| Patient ID . | Age at GT (mo) . | Time point after GT (mo) . | Variant detected (pos/neg) . | Variant/description . | VAF, % . |
|---|---|---|---|---|---|
| 401 | 184 | 0∗ | Negative | — | — |
| 12 | Negative | — | — | ||
| 48 | Negative | — | — | ||
| 72 | Negative | — | — | ||
| 402† | 4 | 0∗ | Positive | KIT- VUS c.1700A>G (p.N567S) | 50 |
| 120 | Positive | KIT- VUS c.1700A>G (p.N567S) | 50 | ||
| 404† | 3 | 0∗ | Positive | KIT- VUS c.1700A>G (p.N567S) | 49 |
| 96 | Positive | KIT- VUS c.1700A>G (p.N567S) | 49 | ||
| 405 | 8 | 0∗ | Negative | — | — |
| 48 | Negative | — | — | ||
| 96 | Negative | — | — | ||
| 407 | 14 | 60 | Negative | — | — |
| 408 | 3 | 48 | Negative | — | — |
| 409 | 20 | 0∗ | Negative | — | — |
| 84 | Negative | — | — | ||
| 410 | 3 | 36 | Positive | TP53- LB c.1015G>A (p.E339K) | 48 |
| Controls ×5 | N/A | N/A | Negative | — | — |